Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 166 AL 180

[Bioinks and in vitro neurovascular unit production - New prospects in Alzheimer's disease research]

Lougiaki P, Tsolaki M, Pantazaki A.

Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:209-222.

GABAergic astrocytes in Alzheimer's disease

Garaschuk O, Verkhratsky A.

Aging (Albany NY). 2019 Mar 15;11(6):1602-1604. doi: 10.18632/aging.101870.

Understanding the Amyloid Hypothesis in Alzheimer's Disease

Paroni G, Bisceglia P, Seripa D.

J Alzheimers Dis. 2019;68(2):493-510. doi: 10.3233/JAD-180802.

Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease

Wang T, Liu XH, Guan J, Ge S, Wu MB, Lin JP, Yang LR.

Eur J Med Chem. 2019 May 1;169:200-223. doi: 10.1016/j.ejmech.2019.02.076. Epub 2019 Mar 5.

Traditional Ayurvedic and herbal remedies for Alzheimer's disease: from bench to bedside

Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK.

Expert Rev Neurother. 2019 May;19(5):359-374. doi: 10.1080/14737175.2019.1596803. Epub 2019 Apr 10.

ApoE4: an emerging therapeutic target for Alzheimer's disease

Safieh M, Korczyn AD, Michaelson DM.

BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4.

Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis

Cao J, Zhong MB, Toro CA, Zhang L, Cai D.

Neurosci Lett. 2019 Jun 11;703:68-78. doi: 10.1016/j.neulet.2019.03.016. Epub 2019 Mar 16.

Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer's Disease

Ali F, Siddique YH.

CNS Neurol Disord Drug Targets. 2019;18(5):352-365. doi: 10.2174/1871527318666190319141835.

Validation of an Magnetic Resonance Imaging Acquisition and Review Protocol for Alzheimer's Disease and Related Disorders

Asselin A, Potvin O, Bouchard LO, Brisson M, Duchesne S.

Can Assoc Radiol J. 2019 May;70(2):172-180. doi: 10.1016/j.carj.2018.10.008. Epub 2019 Mar 17.

The vexing complexity of the amyloidogenic pathway

Castro MA, Hadziselimovic A, Sanders CR.

Protein Sci. 2019 Jul;28(7):1177-1193. doi: 10.1002/pro.3606. Epub 2019 Apr 11.

Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders

Golde TE.

Neuron. 2019 Mar 20;101(6):1003-1015. doi: 10.1016/j.neuron.2019.02.027.

Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines

Sharman MJ, Verdile G, Kirubakaran S, Parenti C, Singh A, Watt G, Karl T, Chang D, Li CG, Münch G.

CNS Drugs. 2019 May;33(5):457-480. doi: 10.1007/s40263-019-00619-1.

Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis

Foroutan N, Hopkins RB, Tarride JE, Florez ID, Levine M.

Clin Invest Med. 2019 Mar 23;42(1):E53-E65. doi: 10.25011/cim.v42i1.32393.

Can magnesium reduce central neurodegeneration in Alzheimer's disease? Basic evidences and research needs

Toffa DH, Magnerou MA, Kassab A, Hassane Djibo F, Sow AD.

Neurochem Int. 2019 Jun;126:195-202. doi: 10.1016/j.neuint.2019.03.014. Epub 2019 Mar 22.

Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy

Illán-Gala I, Montal V, Borrego-Écija S, Vilaplana E, Pegueroles J, Alcolea D, Sánchez-Saudinós B, Clarimón J, Turón-Sans J, Bargalló N, González-Ortiz S, Rosen HJ, Gorno-Tempini ML, Miller BL, Lladó A, Rojas-García R, Blesa R, Sánchez-Valle R, Lleó A, Fortea J; Catalan Frontotemporal Dementia Initiative (CATFI) and the Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI).

Brain. 2019 Apr 1;142(4):1121-1133. doi: 10.1093/brain/awz031.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias